Research graph
References from The effect of a single dose of methylphenidate on attention in children and adolescents with ADHD and comorbid Oppositional Defiant Disorder. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1176/appi.books.9780890425596
10.1176/appi.books.9780890425596 · External reference
ADHD prevalence estimates in Italian children and adolescents: a methodological issue
10.1186/s13052-018-0545-2 · 2018 · External reference
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
10.1007/s00787-009-0054-3 · 2010 · External reference
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
10.1016/s2215-0366(18)30269-4 · 2018 · External reference
The influence of comorbid oppositional defiant disorder on white matter microstructure in attention-deficit/hyperactivity disorder
10.1007/s00787-015-0784-3 · 2016 · External reference
Experiences of physical and relational victimization in children with ADHD: The role of social problems and aggression
10.1002/ab.21762 · 2018 · External reference
Neuropsychological Predictors of ODD Symptom Dimensions in Young Children
10.1080/15374416.2016.1266643 · 2019 · External reference
Impaired Neurocognitive Functions Affect Social Learning Processes in Oppositional Defiant Disorder and Conduct Disorder: Implications for Interventions
10.1007/s10567-012-0118-7 · 2012 · External reference
Investigation of cool and hot executive function in ODD/CD independently of ADHD: Cool and hot executive function in ODD/CD
10.1111/j.1469-7610.2011.02454.x · 2011 · External reference
Executive function deficits in preschool children with ADHD and DBD: Executive functions in preschoolers with ADHD and DBD
10.1111/j.1469-7610.2011.02468.x · 2012 · External reference
Relations between response trajectories on the continuous performance test and teacher-rated problem behaviors in preschoolers
10.1037/pas0000054 · 2015 · External reference
Visuospatial Working Memory in 7- to 12-Year-Old Children with Disruptive Behavior Disorders
10.1007/s10578-014-0449-3 · 2015 · External reference
Clinical and Neuropsychological Predictors of Methylphenidate Response in Children and Adolescents with ADHD: A Naturalistic Follow-up Study in a Spanish Sample
10.2174/1745017901915010160 · 2019 · External reference
Individual Variability in Reaction Time and Prediction of Clinical Response to Methylphenidate in Adult ADHD: A Prospective Open Label Study Using Conners’ Continuous Performance Test II
10.1177/1087054719829822 · 2021 · External reference
Effects of Methylphenidate on Cognitive Functions in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Evidence from a Systematic Review and a Meta-Analysis
10.1016/j.biopsych.2013.10.005 · 2014 · External reference
Effects of methylphenidate on reaction time in children with Attention Deficit Hyperactivity Disorder
2018 · External reference
Assessing medication effects in the MTA study using neuropsychological outcomes
10.1111/j.1469-7610.2005.01469.x · 2006 · External reference
Stimulant Treatment Reduces Lapses in Attention among Children with ADHD: The Effects of Methylphenidate on Intra-Individual Response Time Distributions
10.1007/s10802-009-9316-2 · 2009 · External reference
Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder
10.1016/s0006-3223(03)00609-7 · 2003 · External reference
Methylphenidate Improves Visual-Spatial Memory in Children With Attention-Deficit/Hyperactivity Disorder
10.1097/00004583-200403000-00006 · 2004 · External reference
Immediate effects of methylphenidate on cognitive attention skills of children with attention-deficit–hyperactivity disorder
2005 · External reference
The top and the bottom of ADHD: a neuropsychological perspective
10.1016/j.neubiorev.2003.08.004 · 2003 · External reference
The Nature of Executive Function (EF) Deficits in Daily Life Activities in Adults with ADHD and Their Relationship to Performance on EF Tests
10.1007/s10862-011-9217-x · 2011 · External reference
Stability of Executive Function Deficits in Girls with ADHD: A Prospective Longitudinal Followup Study into Adolescence
10.1080/87565640701729755 · 2007 · External reference
Methylphenidate Normalizes Frontocingulate Underactivation During Error Processing in Attention-Deficit/Hyperactivity Disorder
10.1016/j.biopsych.2011.04.018 · 2011 · External reference
ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD: ADHD frontostriatal dysfunction
10.1111/j.1469-7610.2007.01761.x · 2007 · External reference
Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task
10.1016/j.neuropharm.2009.08.013 · 2009 · External reference
Prediction of Clinical Response to Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder
10.1097/00004583-199508000-00012 · 1995 · External reference
Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial
10.1038/npp.2015.128 · 2015 · External reference
A systematic review to identify the factors that affect failure to rescue and escalation of care in surgery
10.1016/j.surg.2014.10.017 · 2015 · External reference
A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression
10.1097/jcp.0000000000000747 · 2017 · External reference
Long-Acting Methylphenidate Has an Effect on Aggressive Behavior in Children with Attention-Deficit/Hyperactivity Disorder
10.1089/cap.2007.0011 · 2007 · External reference
Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?
10.1097/hrp.0000000000000122 · 2017 · External reference
Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder
10.1016/j.jsat.2012.07.001 · 2013 · External reference
Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
10.1007/s00787-012-0286-5 · 2012 · External reference
Clinical Response to Methylphenidate in Children Diagnosed with Attention-Deficit Hyperactivity Disorder and Comorbid Psychiatric Disorders
10.1177/070674371005500506 · 2010 · External reference
Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?
10.2147/ndt.s128086 · 2017 · External reference
Unresolved reference
2000 · External reference
10.1007/978-0-387-79061-9_3066
10.1007/978-0-387-79061-9_3066 · 2011 · External reference
Unresolved reference
1998 · External reference
10.1007/978-0-387-79948-3_1059
10.1007/978-0-387-79948-3_1059 · 2011 · External reference
Unresolved reference
2019 · External reference
A Children’s Global Assessment Scale (CGAS)
10.1001/archpsyc.1983.01790100074010 · 1983 · External reference
Unresolved reference
2007 · External reference
Unresolved reference
1991 · External reference
Long-term outcomes of youth who manifested the CBCL-Pediatric Bipolar Disorder phenotype during childhood and/or adolescence
10.1016/j.jad.2008.05.024 · 2009 · External reference
Emotional dysregulation and callous unemotional traits as possible predictors of short-term response to methylphenidate monotherapy in drug-naïve youth with ADHD
10.1016/j.comppsych.2020.152178 · 2020 · External reference
Correlates of the CBCL-dysregulation profile in preschool-aged children: CBCL-dysregulation profile in preschoolers
10.1111/j.1469-7610.2012.02546.x · 2012 · External reference
10.1007/978-0-387-79948-3_1506
10.1007/978-0-387-79948-3_1506 · 2011 · External reference
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
10.3758/bf03193146 · 2007 · External reference
Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis
10.1017/s0033291716000350 · 2016 · External reference
Early development of comorbidity between symptoms of attention-deficit/hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD)
10.1037/abn0000090 · 2016 · External reference
Cool and hot executive function in conduct-disordered adolescents with and without co-morbid attention deficit hyperactivity disorder: relationships with externalizing behaviours
10.1017/s0033291712003078 · 2013 · External reference
Building a Clinically Relevant Cognitive Task: Case Study of the AX Paradigm
10.1093/schbul/sbn038 · 2007 · External reference
Methylphenidate Normalizes Fronto-Striatal Underactivation During Interference Inhibition in Medication-Naïve Boys with Attention-Deficit Hyperactivity Disorder
10.1038/npp.2011.30 · 2011 · External reference
Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task
10.1016/j.neuropharm.2009.08.013 · 2009 · External reference
Disorder-specific functional abnormalities during sustained attention in youth with Attention Deficit Hyperactivity Disorder (ADHD) and with Autism
10.1038/mp.2011.185 · 2013 · External reference
Neural Correlates of Adolescent Irritability and Its Comorbidity With Psychiatric Disorders
10.1016/j.jaac.2019.11.028 · 2020 · External reference
A Systematic Review and Meta-analysis of Neuroimaging in Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) Taking Attention-Deficit Hyperactivity Disorder (ADHD) Into Account
10.1007/s11065-015-9315-8 · 2016 · External reference
Neural Correlates of the Propensity for Retaliatory Behavior in Youths With Disruptive Behavior Disorders
10.1176/appi.ajp.2015.15020250 · 2016 · External reference
Reduced Amygdala Response to Fearful Expressions in Children and Adolescents With Callous-Unemotional Traits and Disruptive Behavior Disorders
10.1176/appi.ajp.2007.07071145 · 2008 · External reference
Disrupted Reinforcement Signaling in the Orbitofrontal Cortex and Caudate in Youths With Conduct Disorder or Oppositional Defiant Disorder and a High Level of Psychopathic Traits
10.1176/appi.ajp.2010.10010129 · 2011 · External reference
An Open-Label Trial of Methylphenidate Treating Sluggish Cognitive Tempo, Inattention, and Hyperactivity/Impulsivity Symptoms Among 6- to 12-Year-Old ADHD Children: What Are the Predictors of Treatment Response at Home and School?
10.1177/1087054720902846 · 2021 · External reference
Six months methylphenidate treatment improves emotion dysregulation in adolescents with attention deficit/hyperactivity disorder: a prospective study
10.2147/ndt.s164807 · 2018 · External reference
Neurocognitive Deficits in Attention-Deficit/Hyperactivity Disorder With and Without Comorbid Oppositional Defiant Disorder
10.1177/1087054715606216 · 2020 · External reference
Oppositional Defiant Disorder Symptoms in Relation to Psychopathic Traits and Aggression Among Psychiatrically Hospitalized Children: ADHD Symptoms as a Potential Moderator: ADHD+ODD, Psychopathic Traits, and Aggression
10.1002/ab.21471 · 2013 · External reference
Psychopathy traits in adolescents with childhood attention-deficit hyperactivity disorder
10.1192/bjp.bp.107.046870 · 2009 · External reference
The Unique Contribution of Emotional Impulsiveness to Impairment in Major Life Activities in Hyperactive Children as Adults
2010 · External reference
Effect of Methylphenidate on Emotional Dysregulation in Children With Attention-Deficit/Hyperactivity Disorder + Oppositional Defiant Disorder/Conduct Disorder
10.1097/jcp.0000000000000668 · 2017 · External reference
Treatment of Childhood Oppositional Defiant Disorder
10.1007/s40746-015-0015-7 · 2015 · External reference
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Oppositional Defiant Disorder
10.1097/01.chi.0000246060.62706.af · 2007 · External reference
A Pilot Study of Methyiphenidate, Clonidine, or the Combination in ADHD Comorbid with Aggressive Oppositional Defiant or Conduct Disorder
10.1177/000992280003900102 · 2000 · External reference
Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6–12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial
2010 · External reference
Atomoxetine Treatment in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder
10.1097/00004583-200503000-00008 · 2005 · External reference
Combined pharmacotherapy-multimodal psychotherapy in children with Disruptive Behavior Disorders
10.1016/j.psychres.2016.02.010 · 2016 · External reference
Family Routine Moderates the Relation Between Child Impulsivity and Oppositional Defiant Disorder Symptoms
10.1007/s10802-010-9447-5 · 2011 · External reference
NICE guideline: attention deficit hyperactivity disorder
10.1136/adc.2009.175943 · 2010 · External reference
Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
10.2147/ndt.s130444 · 2017 · External reference
A Dose-Response Study of OROS Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder
10.1542/peds.112.5.e404 · 2003 · External reference
